Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Mongodb Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.04B), while Mongodb Inc trades at $347.22 (market cap $27.72B). The key difference: Mongodb Inc is far larger — about 3.4× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap. Which is the better fit depends on your goals.
| BIO | MDB | |
|---|---|---|
Market Cap | $8.04B | $27.72B |
Sector | Health | Technology |
52-Week High | $339.75 | $440.25 |
52-Week Low | $241.71 | $201.08 |
Enterprise Value | $7.85B | $25.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MongoDB (MDB) trades at $337.59, down 1.31% on the day, with a bullish technical signal from moving averages and oversold short-term RSI. Revenue growth remains strong, reaching $2.01 billion in 2025, though the company is not yet profitable, posting a net loss of $129 million. Recent news highlights AI-driven demand boosting database sales, with the company raising FY2027 revenue guidance to $2.92–$2.96 billion, signaling robust growth prospects.
The outlook is positive given strong analyst support (81.8% buy ratings) and a $400.39 consensus price target, implying 18.6% upside. Key risks include ongoing losses, competitive pressures, and potential legal scrutiny from shareholder investigations. Earnings beats in recent quarters and projected narrowing losses by 2026 support a growth-oriented investment case, but profitability remains a critical watchpoint.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
